ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,525.21
      0.74%
      US Tech 100
      18,919.76
      1.21%
      Dow Jones
      40,113.50
      0.05%
      Brent Oil
      66.025
      0.00%
      Bitcoin
      94,243.49
      -0.50%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Bellevue Life Sciences Acquisition Corporation (BLAC) Quote

      Bellevue Life Sciences Acquisition Corporation

      Bellevue Life Sciences Acquisition Corporation (BLAC)

      NASDAQ
      3.01
      0.00
      (0.00%)
      Closed April 26 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      3.01
      Bid
      2.70
      Ask
      2.85
      Volume
      -
      0.00 Day's Range 0.00
      3.01 52 Week Range 13.30
      Market Cap
      16.925M
      Previous Close
      3.01
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      10,026
      Shares Outstanding
      5,622,954
      Dividend Yield
      -
      PE Ratio
      19.08
      Earnings Per Share (EPS)
      0.07
      Revenue
      -
      Net Profit
      404k

      About Bellevue Life Sciences Acquisition Corporation

      OSR is a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. OSR aims to build and develop a robust portfolio of innovative and potentially transformative therapies and healthcare solutions. Its current operating busin... OSR is a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. OSR aims to build and develop a robust portfolio of innovative and potentially transformative therapies and healthcare solutions. Its current operating businesses (through three wholly-owned subsidiaries) include (i) developing oral immunotherapies for the treatment of cancer, (ii) developing design-augmented biologics for age-related and other degenerative diseases and (iii) neurovascular intervention medical device and systems distribution in Korea. OSR's vision is to acquire and operate a portfolio of innovative health-care related companies globally. Show more

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Bellevue Life Sciences Acquisition Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker BLAC. The last closing price for Bellevue Life Sciences A... was $3.01. Over the last year, Bellevue Life Sciences A... shares have traded in a share price range of $ 3.01 to $ 13.30.

      Bellevue Life Sciences A... currently has 5,622,954 shares outstanding. The market capitalization of Bellevue Life Sciences A... is $16.93 million. Bellevue Life Sciences A... has a price to earnings ratio (PE ratio) of 19.08.

      Ask ADVFN Intelligence (AI)

      BLAC Latest News

      More News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1003.013.013.0100CS
      4003.013.013.0100CS
      12-8.39-73.596491228111.411.843.01100264.63913385CS
      26-7.94-72.511415525110.9513.33.0177597.32637332CS
      52-7.68-71.842843779210.6913.33.0192019.35613928CS
      156-7.19-70.490196078410.213.33.011477210.09945669CS
      260-7.19-70.490196078410.213.33.011477210.09945669CS

      BLAC - Frequently Asked Questions (FAQ)

      What is the current Bellevue Life Sciences A... share price?
      The current share price of Bellevue Life Sciences A... is $ 3.01
      How many Bellevue Life Sciences A... shares are in issue?
      Bellevue Life Sciences A... has 5,622,954 shares in issue
      What is the market cap of Bellevue Life Sciences A...?
      The market capitalisation of Bellevue Life Sciences A... is USD 16.93M
      What is the 1 year trading range for Bellevue Life Sciences A... share price?
      Bellevue Life Sciences A... has traded in the range of $ 3.01 to $ 13.30 during the past year
      What is the PE ratio of Bellevue Life Sciences A...?
      The price to earnings ratio of Bellevue Life Sciences A... is 19.08
      What is the reporting currency for Bellevue Life Sciences A...?
      Bellevue Life Sciences A... reports financial results in USD
      What is the latest annual profit for Bellevue Life Sciences A...?
      The latest annual profit of Bellevue Life Sciences A... is USD 404k
      What is the registered address of Bellevue Life Sciences A...?
      The registered address for Bellevue Life Sciences A... is 8 THE GREEN, STE R, KENT, DOVER, DELAWARE, 19901
      Which industry sector does Bellevue Life Sciences A... operate in?
      Bellevue Life Sciences A... operates in the SURGICAL,MED INSTR,APPARATUS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WWWW International Inc
      $ 0.395
      (167.62%)
      		223.58M
      OMEXOdyssey Marine Exploration Inc
      $ 1.4979
      (75.79%)
      		285.65M
      RTCBaijiayun Group Ltd
      $ 0.3244
      (74.88%)
      		263.23M
      GREEGreenidge Generation Holdings Inc
      $ 1.3197
      (53.92%)
      		5.84M
      SXTCChina SXT Pharmaceuticals Inc
      $ 2.28
      (44.30%)
      		38.04M
      CGTLCreative Global Technology Holdings Ltd
      $ 1.5197
      (-75.09%)
      		3.88M
      TOIIWOncology Institute Inc
      $ 0.1015
      (-40.22%)
      		156.14k
      COEPCoeptis Therapeutics Holdings Inc
      $ 7.70
      (-38.25%)
      		716.99k
      INTSIntesity Therapeutics Inc
      $ 0.56
      (-37.78%)
      		3.21M
      SMMTSummit Therapeutics Inc
      $ 23.47
      (-36.05%)
      		24.67M
      GNLNGreenlane Holdings Inc
      $ 0.012699
      (-15.34%)
      		355.22M
      AGMHAGM Group Holdings Inc
      $ 0.0477
      (22.31%)
      		340.91M
      OMEXOdyssey Marine Exploration Inc
      $ 1.4979
      (75.79%)
      		285.65M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 10.455
      (19.62%)
      		266.95M
      RTCBaijiayun Group Ltd
      $ 0.3244
      (74.88%)
      		263.23M

      Discussion

      View Full Feed
      Golden Cross Golden Cross 4 minutes ago
      $BNCM DELEX is poised to become a dominant player in the global healthcare market.

      Explore DELEX's Strengths and Growth Plans Below. ⬇️
      https://bncm.net/bncm-delex-expansion-plans/

      1. 15 Years of Robust Business Growth:
      DELEX Pharma’s legacy is built on 1
      BNCM
      Stinger2014 Stinger2014 4 minutes ago
      I may miss the event for a. …ROAD TRIP!!
      Hey Elon, need that tunnel digger!
      CGAC
      zab zab 4 minutes ago
      Trump also canceled VOA, voice over America the satellite service being used for communication,  the BBC stepped in to give service to help in the disaster recovery. 
      Monksdream Monksdream 5 minutes ago
      PLRX under $2
      https://investorshub.advfn.com/uimage/uploads/2025/4/26/whycbIMG_6330.gif
      PLRX
      willpellel willpellel 5 minutes ago
      I never lied about 1 thing. Calling me out on a lie requires that i made a statement that is not factual. That has NEVER happened here.
      If you believe I have, tell me the specific lie!!!
      PSRU
      Golden Cross Golden Cross 5 minutes ago
      $BNCM DELEX is poised to become a dominant player in the global healthcare market.

      Explore DELEX's Strengths and Growth Plans Below. ⬇️
      https://bncm.net/bncm-delex-expansion-plans/

      1. 15 Years of Robust Business Growth:
      DELEX Pharma’s legacy is built on 1
      BNCM
      al44 al44 5 minutes ago
      Someone knows how to do it-

      https://media.gettr.com/group5/getter/2025/04/26/15/3f8c1e15-3cfd-3fd5-e047-b672fed1b60b/32036e74d0f32c2b5537c398e64bd1d9_768x0.jpg
      Investor2014 Investor2014 6 minutes ago
      Did you ask ChatGPT to include references to the specific information used to come up that percentage and then read them yourself to determine if the answer might have been relevant and correct?
      AVXL
      pegs1 pegs1 7 minutes ago
      Quick shift
      Are you kidding me? I saw the post from Hilo. I took him with a grain of salt!
      CRTG
      Monksdream Monksdream 7 minutes ago
      VIGL under $2
      https://investorshub.advfn.com/uimage/uploads/2025/4/26/dlevoIMG_6329.gif
      VIGL
      KRISGO KRISGO 8 minutes ago
      thanks! Yeah, I didn’t notice it at first in all the excitement. When I initially asked ChatGPT, it said DCVax wasn’t in the DrugBank system. Still, this feels like a positive sign. They could’ve added it around this time last year, but why now? Maybe they were recently informed of something.
      NWBO
      zab zab 8 minutes ago
      Follow up on the three team Americans sent by trump to Myanmar,  trump fired them all after they arrived. 
      XMaster2023 XMaster2023 9 minutes ago
      I think the UK has the biggest financial incentive to approve DCVax-L
      NWBO
      Monksdream Monksdream 9 minutes ago
      HUMA, under $2
      https://investorshub.advfn.com/uimage/uploads/2025/4/26/lfoxrIMG_6328.gif
      HUMA
      BDEZ BDEZ 9 minutes ago
      In Biden's first April term over 400 J6ers were jailed..........Trump needs to get busy & handle the Commies....
      Investor2014 Investor2014 9 minutes ago
      So you don't actually believe the broad stroke >83% chance of approval for an accepted MAA applies to Anavex and CNS?

      How then do you think the Clock Stop Stats fall out in CNS and how different are they to those we can see for Oncology?

      Hoskuld provided the link I had
      AVXL
      Eli's Gone Eli's Gone 10 minutes ago
      GL..
      mascale mascale 10 minutes ago
      Noting AAGC Quarterly Reports: First half AAGC revenue of $1,454,182 was almost matched in Q3 alone: Increase of $1,206,484--AAGC 4/14/2025. That shows AAGC Q3 total at $2,661,666, on its way to likely $5.0 for the year. Some posters find new technology an unsurmountable challenge, a barrier to
      AAGC
      DesertDrifter DesertDrifter 10 minutes ago
      LOL, getting lectured about stupidity from a high school dropout. How is that fentanyl working out for you?
      janetcanada janetcanada 10 minutes ago
      👀***Post Your Credential!.....Otherwise is Just Your Opinion⁉️......

      ☯️***- OPINION V/S KNOWLEDGE

      ❗️***Opinion:

      ***Is a Personal Belief or Judg
      GCAN
      iateclube iateclube 11 minutes ago
      Now that is funny, you beat me to it....
      LQMT
      SSKILLZ1 SSKILLZ1 11 minutes ago
      VMIR

      The VMIR is Down -15.61%, after this week’s performance. So without further ado the info is below. Remember This Index Is showed in dollar terms.

      The 86 Original Stocks ($1,000.00)
      [pre]
      Symbol Value Of Investment
      ACCO $742.86
      AMPH $6
      ARMN ETCC OMI
      BDEZ BDEZ 12 minutes ago
      WI Gov. Evers admin instructs all state employees to help illegal immigrants avoid ICE

      https://x.com/IanJaeger29/status/1916208196701544806
      Monksdream Monksdream 12 minutes ago
      IFRX, under $2
      https://investorshub.advfn.com/uimage/uploads/2025/4/26/oryigIMG_6327.gif
      IFRX
      iateclube iateclube 12 minutes ago
      More like a plurality......
      LQMT

      Your Recent History

      NASDAQ
      BLAC
      Bellevue Life Sciences A...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads